Press Release

Drug Eluting Stent Market to Grow with a CAGR of 8.13% through 2028

Increasing prevalence of cardiovascular diseases and growing awareness and education are factors driving the Global Drug Eluting Stent Market in the forecast period 2024-2028.


According to TechSci Research report, “Drug Eluting Stent Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Drug Eluting Stent Market stood at USD 7.09 billion in 2022 and is anticipated to grow with a CAGR of 8.13% in the forecast period, 2024-2028. The global drug-eluting stent (DES) market has witnessed significant growth over the years, driven by a combination of factors ranging from the rising prevalence of cardiovascular diseases to technological advancements in medical devices. Drug-eluting stents are a crucial part of interventional cardiology, offering a less invasive and effective treatment option for patients with coronary artery disease.

One of the primary drivers of the global drug-eluting stent market is the escalating prevalence of cardiovascular diseases (CVDs). Conditions like coronary artery disease (CAD) have become increasingly common worldwide due to factors such as sedentary lifestyles, unhealthy dietary habits, and an aging population. Drug-eluting stents are widely used in the treatment of CAD, making them an essential medical device in managing this global health issue.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Drug Eluting Stent Market.”


Advancements in stent design and materials have greatly contributed to the growth of the DES market. Manufacturers are constantly innovating to develop stents with improved drug-elution capabilities, biocompatibility, and reduced risk of complications. The introduction of bioresorbable stents, which gradually dissolve in the body, represents a significant breakthrough in this field, as it eliminates the need for a permanent implant. Minimally invasive procedures have gained popularity in the medical community and among patients due to their numerous benefits, including reduced hospital stays, quicker recovery times, and lower risk of infection. Drug-eluting stents are a key component of percutaneous coronary interventions (PCI), a minimally invasive approach to treat coronary artery disease. This trend has led to an increased demand for DES, as patients and physicians prefer these less invasive procedures.

Rising healthcare expenditure in both developed and developing countries is a significant factor contributing to the growth of the global drug-eluting stent market. Governments and private healthcare providers are investing in advanced medical technologies, including DES, to improve patient outcomes and reduce the economic burden of cardiovascular diseases on healthcare systems.

Public awareness campaigns and educational initiatives about cardiovascular diseases and their treatment options have played a role in increasing the adoption of drug-eluting stents. As people become more informed about the benefits of DES in comparison to traditional treatments, there is a growing preference for this technology among patients and healthcare professionals alike. The Global Drug Eluting Stent Market is segmented into Coating Type, End Use  and company.

Based on End Use , the Coronary artery disease segment has emerged as the predominant market leader. Pharmaceutical and medical device companies have invested significantly in research and development to produce newer and more advanced drug-eluting stents. This competitive landscape fosters innovation and the development of stents that are better suited for Coronary artery disease treatment.

Based on region, North America segment is expected to grow during the forecast period.  Healthcare providers in North America have access to extensive resources for medical education and training. This helps ensure that healthcare professionals are well-informed about the benefits of drug-eluting stents and are more likely to recommend them to patients when appropriate.

The Asia Pacific region is experiencing rapid market growth. Pharmaceutical and medical device companies in Asia Pacific invest heavily in research and development to create new drug-eluting stent technologies. These investments lead to product improvements and expanded treatment options.


Major companies operating in Global Drug Eluting Stent Market are:

  • Abbott Laboratories ltd.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Biosensors International Ltd
  • Cook Medical pvt ltd.
  • B. Braun Medical (India) Private Limited
  • Biotronik, Inc.
  • Lepu Medical Technology Inc.


Download Free Sample Report

Customers can also request 10% free customization in this report.


“The global drug-eluting stent market is poised for continued growth due to the convergence of several key drivers. The increasing prevalence of cardiovascular diseases, technological innovations, the popularity of minimally invasive procedures, the aging population, healthcare spending, education, and reimbursement policies are all contributing to the expansion of this vital medical device market. As these factors continue to evolve, the market for drug-eluting stents is expected to advance, providing better treatment options and improved outcomes for patients with coronary artery disease and other cardiovascular conditions.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Drug Eluting Stent Market By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings(Micro porous Surface, Micro structured Surface, Slotted tubular Surface, Nanoporous Surface)), By Application (Coronary Artery Disease, Peripheral Artery Disease), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Drug Eluting Stent Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Drug Eluting Stent Market.


Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               


Relevant News